New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Soleno Therapeutics, Inc.
SLNO
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2B

Biotechnology

Next Earning date - 05 Nov 2024

2B

Biotechnology

Next Earning date - 05 Nov 2024

53.75USD
Shape-0.41 ( -0.76%)
favorite-chart

Relative Strenght

100
favorite-chart

Volume Buzz

-10%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

5%

Quote Panel

Shape
Updated October 22, 2024
1W -1.38 % 1M 11.65 % 3M 11.05 % 1Y 124.52 %

Key Metrics

Shape
  • Market Cap

    2.09B


  • Shares Outstanding

    38.87M


  • Share in Float

    27.68M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    53.75


  • Average Volume

    593832


  • Beta

    -1.448


  • Range

    21.3-56.81


  • Industry

    Biotechnology


  • Website

    https://soleno.life


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

610.94x

P/S Ratio

7.45x

P/B Ratio

0.0

Debt/Equity

-1898.1%

Net Margin

$-1.8

EPS

How SLNO compares to sector?

P/E Ratio

Relative Strength

Shape

SLNO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$38M

ShapeNaN%

2025-Revenue

$1.99

Shape-249%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

H.C. Wainwright

initialise

Previous: Not converted

2024-09-03

Now: Buy

Cantor Fitzgerald

initialise

Previous: Not converted

2023-07-11

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.76
vs -1.50

Q4.22

arrow
arrow

N/A

-0.40
vs -0.53

Q1.23

arrow
arrow

N/A

-0.88
vs -1.05

Q2.23

arrow
arrow

N/A

-0.81
vs -0.90

Q3.23

arrow
arrow

N/A

-0.95
vs -0.76

Q4.23

arrow
arrow

N/A

-0.33
vs -0.40

Q1.24

arrow
arrow

N/A

-0.59
vs -0.88

Q2.24

arrow
arrow

N/A

-0.57
vs -0.81

Q3.24

arrow
arrow

N/A

-0.60
vs -0.95

Q4.24

arrow
arrow

N/A

-0.62
vs -0.33

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

3.4M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-41%

-0.41
vs -0.39

Q4.22

arrow
arrow

-36%

-0.36
vs -0.41

Q1.23

arrow
arrow

-316%

-3.16
vs -0.36

Q2.23

arrow
arrow

-68%

-0.68
vs -3.16

Q3.23

arrow
arrow

-47%

-0.47
vs -0.68

Q4.23

arrow
arrow

-7%

-0.07
vs -0.47

Q1.24

arrow
arrow

-15%

-0.15
vs -0.07

Q2.24

arrow
arrow

-8%

-0.08
vs -0.15

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

18

18
vs 36

-50%

Q4.22

arrow
arrow

23

23
vs 18

28%

Q1.23

arrow
arrow

20

20
vs 23

-13%

Q2.23

arrow
arrow

22

22
vs 20

10%

Q3.23

arrow
arrow

54

54
vs 22

145%

Q4.23

arrow
arrow

84

84
vs 54

56%

Q1.24

arrow
arrow

108

108
vs 84

29%

Q2.24

arrow
arrow

119

119
vs 108

10%

Earnings Growth

Latest News